Skip to content
Search

Latest Stories

Pharmacist Support and Teva UK renew partnership to expand charitable support

Pharmacist Support and Teva UK renew partnership to expand charitable support

Teva UK will continue to be a headline sponsor of Pharmacist Support’s annual Pharmacist ACTNow campaign 

Pharmacist Support and Teva UK have renewed their partnership, committing to expand charitable support across the pharmacy profession.


The collaboration began in 2020 with Teva UK supporting the charity’s inaugural ACTNow wellbeing campaign and has continued to grow since then.

Teva UK, a leader in generics and biopharmaceutical medicines, assists Pharmacist Support in raising awareness about their free and confidential support services, developing mental health and wellbeing resources, and delivering keynote sessions at major pharmacy events.

Additionally, Teva UK will remain a headline sponsor of Pharmacist Support’s annual Pharmacist ACTNow campaign, which supports pharmacists, pharmacy managers and pharmacy teams with mental health and wellbeing in their professionnal and personal lives.

Danielle Hunt, Chief Executive of Pharmacist Support, said: “Our vision is for no one in our pharmacy family to face challenging times without us by their side and, as an independent charity, collaboration is crucial to the success of our charitable work.

“We’re delighted to renew our partnership with Teva UK so that we can raise vital funds and be there for people across our profession who are facing difficulty.”

Kim Innes, General Manager UK at Teva UK, added: “Teva UK is proud to continue our partnership with Pharmacist Support and the important work they do in championing wellbeing within the pharmacy profession.

“As a front-line health service, pharmacy serves as a linchpin in healthcare, providing a valuable service in often challenging and pressurised circumstances.”

Pharmacist Support is an independent charity dedicated to assisting pharmacists, their families, former pharmacists, trainees, and pharmacy students. The charity is funded by donations from pharmacists and pharmacy organisations.

The charity provides a wide variety of free and confidential support services, including information and enquiries, specialist advice, financial assistance, addiction support, counselling and peer support, and the Wardley wellbeing service. Some of these services are delivered directly by trained volunteer pharmacists

Teva UK, a prominent figure in UK healthcare, supplies a diverse range of medicines to the National Health Service (NHS) and collaborates with NHS organisations to enhance the management of long-term health conditions.

Pharmacist Support noted that working with partners such as Teva UK provides them with stability, securing much needed funds to develop and run their vital support services.

 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less